A closer look at the latest operational guidance for the #NHS in England, as it continues to illustrate a disconnect between the messages in big-ticket #policy documents from the central government and the messages from the NHS in England on #medicines. pharmaphorum.com/views-and-anal…

📣📄Delighted to see our paper on policy options for improving access to combination therapies in oncology is out! And what an A team as co-authors!! EPDF: rdcu.be/c7lFm (free) PDF: link.springer.com/article/10.100… (fee) Leela Barham Jaime Espín et al

Patient Groups Want More Say In Talks On New UK Pricing Deal bit.ly/456UG3s #PinkSheet

UK Parliamentarians Call For A New, Internationally Competitive Pricing System bit.ly/3ONefbn #PinkSheet

The People Who Will Shape The UK’s New Drug Pricing Scheme bit.ly/3JgiusL #PinkSheet

PSNC's 2023 pharmacy pressures survey suggested 7% of community pharmacies are profitable, the best for the rest is breakeven. What does that mean for investment for the future? I'm doing a piece for P3pharmacy Magazine. Get in touch! [email protected]

Have you seen a new report on VPAS from LSE, University of York and LSHTM? 👉 lse.ac.uk/News/Latest-ne… I am keen to hear reactions to the report for a Pink Sheet piece; love it, hate it or something in between? Get in touch! [email protected] #pharmaceuticals #VPAS

Have you seen a new position paper on VPAS from @Britishgenerics? 👉 britishgenerics.co.uk/uploads/BGMA-V… What do you make of their ideas? Get in touch to inform a piece for Pink Sheet. [email protected] #pharmaceuticals #VPAS

Can we afford the future of pharmacy? p3pharmacy.co.uk/news/can-we-af…>

HealthWatch England has highlighted issues for some people with their prepayment certificates. How much should - and realistically can - community pharmacies do to help people as they face cost of living issues? Get in touch to inform a piece for P3pharmacy Magazine #communitypharmacy

Do you receive the Healthcare leader's update from NHSE? Do you remember seeing mention of the prepayment certificate in one in the last couple of months? I don't have a copy anymore (too keen to manage my overburdened inbox!) & NHSE won't share. Got a copy please X'ers? 🙏

#NICE ran a webinar on 2nd November, setting out – ahead of formal consultation opening 21st November – plans to increase #fees for #technologyappraisals to help the organisation manage cost pressures and move to cost recovery, as required by legislation. pharmaphorum.com/market-access/…

#NICE ran a webinar on 2nd November, setting out – ahead of formal consultation opening 21st November – plans to increase #fees for #technologyappraisals to help the organisation manage cost pressures and move to cost recovery, as required by legislation. pharmaphorum.com/market-access/…

By ⁦Leela Barham⁩ on our recent publication at ⁦BMJ_Open⁩. ⁦LSE Health Policy⁩ ⁦Marina Kousta⁩ ⁦HTAi⁩ ⁦ABPI⁩ ⁦NICE⁩ ⁦Eric Low⁩ ⁦Wija Oortwijn⁩ pharmaphorum.com/market-access/…